PRIOTHERA

 https://priothera.com/

Background

Priothera is a clinical-stage biopharmaceutical company founded in 2020, with headquarters in Dublin, Ireland, and R&D in France. Led by CEO Florent Gros, the company is dedicated to improving the lives of patients with hematological malignancies. They are pioneering innovative therapies, including their investigational drug mocravimod, to enhance the curative potential of allogeneic hematopoietic cell transplantation (allo-HCT) and CAR T cell therapy, aiming for safer and more effective long-term outcomes.